Myeongin Benztropine Mesylate Tablet 1 mg

Adult dosage

(Oral: Tablets) Adults: The initial dose is 0.5-1㎎ per day as benztropine mesylate, administered orally. Thereafter, increase the dose gradually by 0.5㎎ per day at 5-6 day intervals to reach the maintenance dose. Determine the maintenance dose taking into consideration improvement in symptoms and the occurrence of adverse effects; do not exceed 6㎎ per day. Adjust the dose as appropriate according to age and symptoms. (Injection) ○ Adults 1. The initial dose is 0.5-1㎎ per day as benztropine mesylate, administered by intramuscular or intravenous injection. Thereafter, increase the dose gradually by 0.5㎎ per day at 5-6 day intervals to reach the maintenance dose. Determine the maintenance dose taking into consideration improvement in symptoms and the occurrence of adverse effects; do not exceed 6㎎ per day. 2. In emergencies, inject 1-2㎎ of this medicine to relieve symptoms, then administer 1-2㎎ per dose orally twice daily to prevent recurrence. Use the injection intramuscularly or intravenously in emergencies or when oral administration is not possible. Adjust the dose as appropriate according to age and symptoms.

This drug should not be used in patients with glaucoma, those who are hypersensitive to this medication, patients with myasthenia gravis, and children under the age of 3. Additionally, it should not be administered to patients with genetic conditions such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption, as it contains lactose. Patients with urinary obstructive conditions such as prostate enlargement, patients with arrhythmias or tachycardia, those with impaired liver or kidney function, the elderly, children over the age of 3, and individuals in hot environments should use this medication with caution. When taking this medication, there may be effects on the central nervous system, leading to difficulties in motor control or symptoms such as mental confusion, hallucinations, anxiety, and depression. Gastrointestinal issues may occur, including dry mouth, nausea, vomiting, and constipation, while urological issues may include difficulty urinating or urinary retention. Allergic reactions may also occur, such as skin rashes; therefore, if such symptoms arise, administration should be stopped immediately. Since the drug may impair visual accommodation, caution is advised if there is blurred vision or abnormal sensations in the eyes. When starting the medication, begin with a low dose and gradually increase it while monitoring the condition. When switching from another medication to this one, it is safer to decrease the existing medication slowly while gradually increasing this one. During the course of this medication, it is advisable to have regular eye pressure tests and eye examinations. This drug may enhance the effects of certain psychiatric medications, so it should be taken carefully according to a doctor’s guidance. Also, when used with medications that may cause gastrointestinal issues, there is a risk of bowel obstruction, so consult a doctor immediately if symptoms arise. Pregnant or breastfeeding women should avoid taking this drug as its safety has not been established. Finally, this medication may impair attention and reflexes, so driving or operating hazardous machinery should be avoided.

• Ataxia
• delirium
• hallucinations
• consciousness disturbances
• nonsensical speech
• nervousness
• agitation
• anxiety
• depression
• lethargy

This medication is sensitive to light, so it should be stored in a container that does not allow light to pass through. It is also important to keep it in a sealed container to prevent contact with air.

Appearance

White, round tablet

Package unit

2000 tablets/bottle